Inovio Pharmaceuticals (INO) stock forecast for 2023. Forecast tables and graphs.

Inovio Pharmaceuticals (INO) stock forecast for 2023

The forecast has been updated: October 28, 2021 4:44


Inovio Pharmaceuticals stock price online today

Analyst Target Price

13.22

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

1:4

Last Split Date

06.06.2014

Should you buy or sell Inovio Pharmaceuticals stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Inovio Pharmaceuticals stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $13.22 target price for Inovio Pharmaceuticals stock stock.

Today 200 Day Moving Average is the resistance level (7.97 $).

50 Day Moving Average is the resistance level (7.32 $).




INO Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 6.85 6.62 7.36 9.96 %
Feb 7.29 7.02 7.46 5.86 %
Mar 7.50 7.33 7.89 7.13 %
Apr 7.45 6.90 7.83 11.89 %
May 7.71 7.29 7.91 7.80 %
Jun 7.35 7.19 7.85 8.43 %
Jul 7.35 6.81 7.54 9.66 %
Aug 7.51 7.27 8.10 10.19 %
Sep 7.39 7.14 7.57 5.76 %
Oct 7.33 6.91 7.47 7.55 %
Nov 7.75 7.25 8.19 11.46 %
Dec 7.58 7.18 7.88 8.85 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Inovio Pharmaceuticals stock.


Inovio Pharmaceuticals overview

Inovio Pharmaceuticals Address

6769 MESA RIDGE RD., SAN DIEGO, CA, US

Market Capitalization

1 460 088 000 $

EBITDA

-108 041 976

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-0.754

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.021

Trailing PE

0

Forward PE

0

EV To Revenue

156.01

EV To EBITDA

0

52 Week High

19

52 Week Low

5.81

50 Day Moving Average

7.32

200 Day Moving Average

7.97

Shares Outstanding

210357000

Shares Float

206968000

Shares Short Prior Month

45208500

Short Ratio

14.07

Percent Insiders

1.647

Percent Institutions

35.96

Inovio Pharmaceuticals stock forecast for this year


Inovio Pharmaceuticals stock forecast for Jan 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 6.85. Positive monthly dynamics of the instrument is expected with 9.963% volatility is expected.

Pessimistic forecast: 6.62

Optimistic: 7.36


Inovio Pharmaceuticals stock forecast for Feb 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.29. Positive monthly dynamics of the instrument is expected with 5.859% volatility is expected.

Pessimistic forecast: 7.02

Optimistic: 7.46


Inovio Pharmaceuticals stock forecast for Mar 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.50. Positive monthly dynamics of the instrument is expected with 7.129% volatility is expected.

Pessimistic forecast: 7.33

Optimistic: 7.89


Inovio Pharmaceuticals stock forecast for Apr 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.45. Negative monthly dynamics of the instrument is expected with 11.893% volatility is expected.

Pessimistic forecast: 6.90

Optimistic: 7.83


Inovio Pharmaceuticals stock forecast for May 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.71. Positive monthly dynamics of the instrument is expected with 7.797% volatility is expected.

Pessimistic forecast: 7.29

Optimistic: 7.91


Inovio Pharmaceuticals stock forecast for Jun 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.35. Negative monthly dynamics of the instrument is expected with 8.427% volatility is expected.

Pessimistic forecast: 7.19

Optimistic: 7.85


Inovio Pharmaceuticals stock forecast for Jul 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.35. Negative monthly dynamics of the instrument is expected with 9.659% volatility is expected.

Pessimistic forecast: 6.81

Optimistic: 7.54


Inovio Pharmaceuticals stock forecast for Aug 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.51. Positive monthly dynamics of the instrument is expected with 10.195% volatility is expected.

Pessimistic forecast: 7.27

Optimistic: 8.10


Inovio Pharmaceuticals stock forecast for Sep 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.39. Negative monthly dynamics of the instrument is expected with 5.756% volatility is expected.

Pessimistic forecast: 7.14

Optimistic: 7.57


Inovio Pharmaceuticals stock forecast for Oct 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.33. Negative monthly dynamics of the instrument is expected with 7.549% volatility is expected.

Pessimistic forecast: 6.91

Optimistic: 7.47


Inovio Pharmaceuticals stock forecast for Nov 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.75. Positive monthly dynamics of the instrument is expected with 11.458% volatility is expected.

Pessimistic forecast: 7.25

Optimistic: 8.19


Inovio Pharmaceuticals stock forecast for Dec 2023.
Estimated Average Forecasted Inovio Pharmaceuticals Price: 7.58. Negative monthly dynamics of the instrument is expected with 8.855% volatility is expected.

Pessimistic forecast: 7.18

Optimistic: 7.88



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 127.71 (27.10.2021) -0.33 %
AbbVie Inc.
ABBV 108.4 (27.10.2021) -1.00 %
Aeterna Zentaris Inc.
AEZS 0.6138 (26.10.2021) 4.23 %
Allakos Inc.
ALLK 106.71 (27.10.2021) -4.63 %
Allogene Therapeutics, Inc.
ALLO 15.94 (27.10.2021) -0.50 %
Amgen Inc.
AMGN 206.58 (27.10.2021) -1.01 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.98 (27.10.2021) -1.45 %
Aurora Cannabis Inc.
ACB 6.84 (27.10.2021) -2.70 %
Becton Dickinson and Company
BDX 245 (27.10.2021) -0.55 %
Biogen Inc.
BIIB 259.95 (27.10.2021) -4.12 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 137.1 (27.10.2021) -3.05 %
BioNTech SE
BNTX 278.77 (27.10.2021) -4.66 %
bluebird bio, Inc.
BLUE 22.06 (27.10.2021) 5.30 %
Boston Scientific Corp.
BSX 43.73 (27.10.2021) -1.33 %
Bristol-Myers Squibb Company
BMY 56.49 (27.10.2021) -3.00 %
Canopy Growth Corp.
CGC 12.78 (27.10.2021) -2.96 %
Castle Biosciences, Inc.
CSTL 60.74 (27.10.2021) -1.41 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 250.17 (27.10.2021) 0.70 %
Emergent BioSolutions Inc.
EBS 48.23 (27.10.2021) -4.27 %
Exelixis, Inc.
EXEL 21.3 (27.10.2021) -1.66 %
G1 Therapeutics, Inc.
GTHX 13.39 (27.10.2021) -2.41 %
Gilead Sciences, Inc.
GILD 66.77 (27.10.2021) -1.42 %
GlaxoSmithKline plc
GSK 40.42 (27.10.2021) 0.60 %
GoodRx Holdings, Inc.
GDRX 42.42 (27.10.2021) -4.35 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 64.97 (27.10.2021) -2.37 %
Inovio Pharmaceuticals, Inc.
INO 6.79 (27.10.2021) -0.73 %
Johnson & Johnson
JNJ 163.74 (27.10.2021) -1.21 %
Medtronic plc.
MDT 122.5 (27.10.2021) -1.25 %
Merck & Co., Inc.
MRK 81.54 (27.10.2021) -0.86 %
Moderna, Inc.
MRNA 340.88 (27.10.2021) -1.41 %
Novartis AG
NVS 82.73 (27.10.2021) -2.49 %
Novavax, Inc.
NVAX 141.55 (27.10.2021) 4.86 %
ObsEva SA
OBSV 2.66 (26.10.2021) 1.92 %
OrganiGram Holdings Inc.
OGI 2.24 (27.10.2021) -1.32 %
Pfizer Inc.
PFE 42.97 (27.10.2021) -1.35 %
Regeneron Pharmaceuticals, Inc.
REGN 589.6 (27.10.2021) -0.43 %
Sanofi
SNY 49.57 (27.10.2021) -0.78 %
Schrodinger, Inc.
SDGR 53.73 (27.10.2021) -1.90 %
Senseonics Holdings, Inc.
SENS 3.33 (27.10.2021) -2.63 %
Sorrento Therapeutics, Inc.
SRNE 6.73 (26.10.2021) -1.32 %
Stryker Corp.
SYK 268.5 (27.10.2021) -1.71 %
Sundial Growers Inc.
SNDL 0.6525 (27.10.2021) -1.85 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.93 (27.10.2021) -4.90 %
Thermo Fisher Scientific Inc.
TMO 612.29 (27.10.2021) 0.65 %
Tilray, Inc.
TLRY 10.3 (27.10.2021) -3.83 %
UnitedHealth Group, Inc.
UNH 453.48 (27.10.2021) -0.26 %
Veeva Systems Inc.
VEEV 313.46 (27.10.2021) -2.95 %
Zomedica Corp.
ZOM 0.5 (27.10.2021) -2.84 %
Zynerba Pharmaceuticals, Inc.
ZYNE 3.71 (27.10.2021) -1.33 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.